EGFR and adenocarcinoma: Furthermore, Kobayashi et al. reported the presence of EGFR mutation in 64% of adenocarcinomas presenting as ground‐glass nodules (GGNs), and noted that EGFR mutation‐positive GGNs showed tumor growth to a greater degree than EGFR mutation‐negative GGNs.15